Multimodal data integration with machine learning for predicting PARP inhibitor efficacy and prognosis in ovarian cancer
{{output}}
Background: Poly(ADP)-ribose polymerase inhibitors (PARPi) have brought a significant breakthrough in the maintenance treatment of ovarian cancer. However, beyond BRCA mutation/HRD, the direct impact of other prognostic factors o... ...
